RS28204A - New anhydrous crystalline forms of gabapentin - Google Patents

New anhydrous crystalline forms of gabapentin

Info

Publication number
RS28204A
RS28204A YU28204A YUP28204A RS28204A RS 28204 A RS28204 A RS 28204A YU 28204 A YU28204 A YU 28204A YU P28204 A YUP28204 A YU P28204A RS 28204 A RS28204 A RS 28204A
Authority
RS
Serbia
Prior art keywords
gabapentin
crystalline forms
anhydrous crystalline
new anhydrous
new
Prior art date
Application number
YU28204A
Other languages
English (en)
Inventor
Linna CHEN
Suresh Babu
Claude Jeffrey Calvitt
Brian Tobais
Original Assignee
Warner Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Company filed Critical Warner Lambert Company
Publication of RS28204A publication Critical patent/RS28204A/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38Separation; Purification; Stabilisation; Use of additives
    • C07C227/40Separation; Purification
    • C07C227/42Crystallisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Opisani su novi anhidrovani oblici agabentina dobijenih od gabapentin monohidrata. Novi kristalni oblici omogućavaju poboljšanja u proizvodnji terapeutskih agenasa.
YU28204A 2001-10-09 2002-10-03 New anhydrous crystalline forms of gabapentin RS28204A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32837501P 2001-10-09 2001-10-09
US10/256,155 US6800782B2 (en) 2001-10-09 2002-09-25 Anhydrous crystalline forms of gabapentin
PCT/US2002/031706 WO2003031391A1 (en) 2001-10-09 2002-10-03 New anhydrous crystalline forms of gabapentin

Publications (1)

Publication Number Publication Date
RS28204A true RS28204A (en) 2006-12-15

Family

ID=26945177

Family Applications (1)

Application Number Title Priority Date Filing Date
YU28204A RS28204A (en) 2001-10-09 2002-10-03 New anhydrous crystalline forms of gabapentin

Country Status (27)

Country Link
US (1) US6800782B2 (sr)
EP (1) EP1463712A1 (sr)
JP (1) JP2005505594A (sr)
KR (1) KR20050033525A (sr)
CN (1) CN1568305A (sr)
AP (1) AP2004003025A0 (sr)
BG (1) BG108702A (sr)
BR (1) BR0213156A (sr)
CA (1) CA2462331A1 (sr)
CO (1) CO5570697A2 (sr)
CZ (1) CZ2004416A3 (sr)
EA (1) EA006557B1 (sr)
GE (1) GEP20063936B (sr)
HR (1) HRP20040408A2 (sr)
HU (1) HUP0401782A3 (sr)
IL (1) IL161099A0 (sr)
IS (1) IS7195A (sr)
MA (1) MA27072A1 (sr)
MX (1) MXPA04003301A (sr)
NO (1) NO20041370L (sr)
NZ (1) NZ531993A (sr)
OA (1) OA12665A (sr)
PL (1) PL368117A1 (sr)
RS (1) RS28204A (sr)
SK (1) SK1572004A3 (sr)
TN (1) TNSN04055A1 (sr)
WO (1) WO2003031391A1 (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070043236A1 (en) * 2003-05-19 2007-02-22 Chandiran Thakashina M Process for preparation of gabapentin
WO2004106281A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Crystalline gabapentin
WO2004110342A2 (en) * 2003-06-12 2004-12-23 Matrix Laboratories Ltd Novel polymorph of gabapentin and its conversion to gabapentin form-ii
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
ITMI20040579A1 (it) * 2004-03-25 2004-06-25 Zambon Spa Processo di preparazione di gabapentina
WO2010023694A2 (en) * 2008-09-01 2010-03-04 Hikal Ltd Crystalline forms of gabapentin and process thereof
CN104649921B (zh) * 2015-01-14 2016-09-28 天津大学 一种加巴喷丁与己二酸共晶及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
JPS62247160A (ja) * 1986-03-31 1987-10-28 Aisin Seiki Co Ltd スタ−リングエンジンの始動装置
US4960931A (en) 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
US4894476A (en) 1988-05-02 1990-01-16 Warner-Lambert Company Gabapentin monohydrate and a process for producing the same
DE3928184A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
IL119890A (en) 1996-12-24 2002-03-10 Teva Pharma Gabapentin form iii and preparation of gabapentin form ii
ES2137137B1 (es) 1998-05-25 2000-08-16 Medichem Sa Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.

Also Published As

Publication number Publication date
CA2462331A1 (en) 2003-04-17
EA200400417A1 (ru) 2004-10-28
IL161099A0 (en) 2004-08-31
NZ531993A (en) 2006-09-29
EA006557B1 (ru) 2006-02-24
NO20041370L (no) 2004-04-01
IS7195A (is) 2004-03-23
JP2005505594A (ja) 2005-02-24
OA12665A (en) 2006-06-19
SK1572004A3 (sk) 2005-03-04
CZ2004416A3 (cs) 2005-03-16
HUP0401782A2 (hu) 2005-10-28
HRP20040408A2 (en) 2004-10-31
CN1568305A (zh) 2005-01-19
GEP20063936B (en) 2006-10-10
BR0213156A (pt) 2004-09-14
KR20050033525A (ko) 2005-04-12
AP2004003025A0 (en) 2004-06-30
CO5570697A2 (es) 2005-10-31
PL368117A1 (en) 2005-03-21
MXPA04003301A (es) 2004-07-23
EP1463712A1 (en) 2004-10-06
US20030092933A1 (en) 2003-05-15
TNSN04055A1 (fr) 2006-06-01
MA27072A1 (fr) 2004-12-20
US6800782B2 (en) 2004-10-05
HUP0401782A3 (en) 2006-01-30
WO2003031391A1 (en) 2003-04-17
BG108702A (en) 2005-05-31

Similar Documents

Publication Publication Date Title
GEP20105036B (en) Perindopril
HK1073997A1 (en) Administration of agents for the treatment of inflammation
GEP20074098B (en) Lactam-containing compounds and derivatives thereof as factor xa inhibitors
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
EP1769791A3 (en) Treatment of Alzheimer's disease with cell cycle inhibitors
IS6069A (is) N-cýanómetýlamíð sem próteasalatar
MXPA03010766A (es) Nuevos compuestos y composiciones como inhibicores de las catepsinas.
AP2004003025A0 (en) New anhydrous crystalline forms of gabapentin
IL163871A0 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
MY129370A (en) New anhydrous crystalline forms of gabapentin
PL397022A1 (pl) Środek leczniczy
GB0003048D0 (en) The therapeutic use of polysulphonated polyglycosides or other polyanionic compounds in autism
ITTO20020997A1 (it) Procedimento autoalllineato per la fabbricazione di
EP1488800A4 (en) MEDICINE FOR THE TREATMENT OF PROTOCOL DISEASES
UA67433A (en) Treatment-and-prophylaxis urolit composition
AU2003227519A1 (en) The use of milnacipran for the treatment of tension-type headache
AU2003244633A1 (en) Methods for the treatment of sinusitis
AU2003222141A8 (en) Ctla4 compositions in the treatment of autism
AP2002002566A0 (en) Monohydrate of cis-lithium-cynao-4-Ä3-(cyclopentloxy)-4-methoxyphenylÜ cyclohexanecarboxylate
WO2002055064A3 (en) Mucopolysaccharidosis therapies
ECSP045042A (es) Nuevas formas cristalinas anhidras de la gabapentina
CR7318A (es) Nuevas formas cristalinas anhidras de la gabapentina
SI1503747T1 (sl) Sestavek na osnovi diklofenaka za topicno zdravljenje motenj orofaringealne votline